PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

lung cancer pulmonary nodule chest

Preoperative PET/CT imaging linked with better survival in advanced lung cancer

PET/CT imaging in these patients increases overall survival depending on the cancer’s stage, with those diagnosed with stage 3A and 3B NSCLC appearing to benefit the most from the exam. 

June 24, 2022
U.S. News & World Report children’s hospitals cardiology heart surgery

Lower doses, faster acquisitions: Experts share how to improve PET scans for peds

This week in AJR, experts shared how they were able to reduce FDG PET scan acquisition times by 33%, thus reducing the amount of total radiation exposure to more vulnerable pediatric patients. 

June 22, 2022
The American Medical Association (AMA) Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe. The policy was adopted at the AMA 2022 meeting. #AMA #AMA175 #AMAmtg #ASNC

AMA supports reimbursement for pharmacologic stress agent regadenoson

The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.

June 22, 2022
SNMMI Image of the Year 68Ga-FAPI-46 PET/CT heart attack acute myocardial infarction

‘Image of the Year’ highlights the predictive power of a new PET imaging agent

The Society of Nuclear Medicine and Molecular Imaging has chosen its 2022 Image of the Year, and it’s one that is sure to interest anyone in the field of cardiac imaging.

June 15, 2022
prostate cancer recurrence on PET outside of SRT guidelines

PSMA PET mapping improves radiation therapy contouring after PCA recurrence

Salvage radiation therapy guidelines for patients with prostate cancer recurrence need to be updated to include findings identified on PSMA PET, according to new research shared at SNMMI’s annual conference this week. 

June 14, 2022

Cutting radiation exposure in half during PET/CT using virtual CT scans

“High-quality artificial intelligence-generated images preserve vital information from raw PET images without the additional radiation exposure from CT scans,” experts involved in the study explained.

June 13, 2022

New radiohybrid PET imaging agent increases detection of prostate cancer recurrence

For 45% to 47% of patients who were deemed negative after conventional baseline scans, the use of the radiohybrid imaging agent resulted in at least one true positive PET finding

May 16, 2022
CT Scan

PET/CT offers 'significant prognostic advantage' to patients newly diagnosed with multiple myeloma

The study, which followed 195 patients recently diagnosed with multiple myeloma (MM), found that a negative PET/CT scan six months after diagnosis and induction therapy was significantly linked with improved survival.

May 13, 2022

Around the web

"Gen AI can help tackle repetitive tasks and provide insights into massive datasets, saving valuable time," Thomas Kurian, CEO of Google Cloud, said Tuesday. 

SCAI and four other major healthcare organizations signed a joint letter in support of intravascular ultrasound. 

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

Trimed Popup
Trimed Popup